Borosil Renewables Q1 FY27: ₹86.6Cr Profit, Sales Up 17.1%

Key takeaways from the quarter

Borosil Renewables Limited (NSE: BORORENEW; BSE: 543212) reported a sharp turnaround in Q1 FY27, moving to profit after a loss-making base quarter last year. For the quarter ended June 30, 2026, consolidated revenue from operations was reported at ₹405.69 crore, up 17.1% year-on-year (YoY) from ₹346.58 crore. Consolidated net profit for the period was ₹86.64 crore, compared with a net loss of ₹203.49 crore in Q1 FY26. The company’s basic and diluted EPS was reported at ₹6.19, improving from a negative EPS of ₹12.56 in Q1 FY26.

In a separate set of updates from the Borosil group, Borosil Scientific Limited also reported Q1 FY27 results and disclosed changes to its ESOP framework. The two updates, taken together, put the focus on profitability swings, operating leverage and governance actions such as board approvals and plan amendments.

What Borosil Renewables reported for Q1 FY27

The company said its unaudited consolidated financial results for Q1 FY27 reflect a strong recovery from the year-ago base quarter. Revenue from operations was stated at ₹405.69 crore for the quarter ended June 30, 2026, compared with ₹346.58 crore in the corresponding quarter. Net profit for the period was ₹86.64 crore, while the year-ago quarter carried a net loss of ₹203.49 crore.

The company also disclosed that Q1 FY26 results were affected by an exceptional item drag of ₹222.31 crore. Profit before tax for Q1 FY27 was reported at ₹117.89 crore and the total tax expense for the quarter was ₹31.25 crore, comprising current tax of ₹31.21 crore and a deferred tax charge of ₹0.15 crore. Total comprehensive income for the period was stated at ₹86.11 crore, which included negative currency translation changes of ₹0.34 crore.

Domestic revenue mix and operating cost line items

Borosil Renewables’ disclosures included a domestic-versus-export split that tilted heavily toward India in Q1 FY27. Domestic revenue was reported at ₹391.40 crore, up 31.5% YoY, while the export contribution was described as marginal in one update.

On the operating cost side, employee benefit outlays were reported at ₹25.51 crore versus ₹36.34 crore YoY, and finance borrowing fees were reported at ₹2.32 crore, down 44.7% YoY. The quarter also included a small share of profit from corporate associates of ₹0.62 crore.

Margin and pricing indicators disclosed by the company

In a quarterly business update, Borosil Renewables stated standalone EBITDA of ₹142 crore on revenue of ₹405.69 crore, with EBITDA margins at 35%. It also reported consolidated EBITDA of ₹141.16 crore, up 103.7% YoY, with consolidated EBITDA margin expanding by 1,480 basis points YoY to 34.8%.

The company cited pricing improvements, with average ex-factory selling prices at ₹160.3 per square millimeter, up from ₹138.1 in the year-ago period and ₹150.2 in the preceding quarter. Separately, it was reported that overseas subsidiaries did not generate revenue in Q1 FY27 and recorded negative EBITDA of ₹0.84 crore, versus net revenue of ₹14.32 crore and negative EBITDA of ₹23.24 crore in the corresponding quarter last year.

Board approvals and key dates investors tracked

Borosil Renewables said its board approved the unaudited financial results for the quarter on July 16, 2026. Another update noted the company presented its Q1 FY27 results on July 17, 2026, alongside commentary on margin expansion and capacity plans being on schedule.

The company also disclosed a senior management change: Borosil Renewables accepted the cessation of Mr. Dilip Acharya as Senior Management Personnel effective July 13, 2026, due to a change in internal reporting structure. He was described as the former General Manager – Human Resources, and the company stated he will continue as an employee.

Snapshot table: Borosil Renewables key figures (Q1 FY27)

Borosil Scientific: profit jump, ESOP amendments, and share price range

Borosil Scientific Limited, a Mumbai-based manufacturer of laboratory glassware and process systems, reported a turnaround in profitability for Q1 FY27 (quarter ended June 30, 2026). It stated standalone net profit surged 1,390% YoY to ₹6.84 crore, while consolidated net profit reached ₹4.36 crore, reversing a consolidated loss of ₹0.42 crore recorded in the corresponding period of FY26. Standalone revenue grew 12.2% YoY to ₹99.90 crore. Another datapoint in the material cited revenue of ₹106.75 crore and net profit of ₹4.36 crore for Q1 FY27.

The board approved Borosil Scientific’s unaudited financial results on August 3, 2026. It also approved amendments to its employee stock option plans, specifically the Special Purpose Employee Stock Option Plan 2023 and the BSL ESOS, subject to shareholder approval. The amendments allow share allotment via a trust route and increase the maximum discount percentage for new option grants from 10% to 20%.

On the market price front, Borosil Scientific’s share price was stated at ₹135.39, with a day high of ₹136.70 and a day low of ₹133.91.

Market impact: what these updates signal

For Borosil Renewables, the combination of higher revenue, improved profitability and margin disclosures points to a materially different earnings profile versus the loss-making year-ago base quarter. The company’s disclosures also highlight a shift toward domestic revenue in the mix, alongside lower employee benefit and borrowing-fee line items in the quarter.

For Borosil Scientific, the quarter’s net profit improvement and the ESOP amendments matter for investors tracking execution and retention measures. The trust route and higher permissible discount cap are governance items that can influence how stock-based compensation is structured, subject to shareholder approval.

Conclusion

Borosil Renewables’ Q1 FY27 print showed a return to profit with ₹86.64 crore consolidated PAT on ₹405.69 crore revenue, backed by reported margin expansion and improved pricing indicators. Borosil Scientific, meanwhile, reported a profit rebound and moved to amend ESOP rules, with board approvals dated August 3, 2026. Investors will now track subsequent quarterly disclosures and any shareholder approvals linked to the ESOP amendments, alongside updates tied to operating performance and mix trends.